NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . November 26th, 2002

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Kidney Cancer - Combination of cytotoxic and antiangiogenic agents diminish renal carcinoma

Melanoma - Research report shows new approach to replacing immune cells to shrink tumors

Cancer Therapy - AntiHIV agent active against malignant cells

Cancer Therapy - Tailor-made cancer drugs: Wave of the future?

Cancer Vaccine - Method to transduce leukemia B cells developed

Hepatocellular Carcinoma - Antisense nucleotides keep cancer cell proliferation in check

Leukemia - UCSD cancer researchers develop new antileukemia strategy

Prostate Cancer - COX-2 a factor in prostate cancer pathogenesis

Adverse Drug Events - Pharmaceutical company reports 39 cancer drug deaths in Japan

Antibody Therapy - HuMax-CD20 program targets lymphomas and autoimmune diseases

Brain Cancer - Novel carmustine formulation receives approval for clinical trial in Britain

Breast Cancer - Metastatic breast cancer vaccine trial to continue

Breast Cancer - Study shows Navelbine boosts Herceptin response without increasing side effects

Cancer Imaging - Novel tracer selects for proangiogenic protein in tumors

Cancer Pain - Radiofrequency ablation successfully treats bone pain

Cancer Prevention - Do certain foods trigger the body's cancer-fighting enzymes?

Cancer Therapies - Clinical trials of antibody underway

Cancer Therapies - Global testing contract signed supporting monoclonal antibody trials

Cancer Therapies - Unlabeled CEA antibody inhibits human tumor growth, enhances drug effects

Cancer Therapy - Bacterial protein kills tumors in mice

Cancer Therapy - Combination of IRESSA and radiation antagonizes tumor vessel growth

Cancer Therapy - Forced overexpression of enzyme inhibitor immobilizes tumor angiogenesis

Cancer Therapy - Roche and Kosan to develop and commercialize Epothilone D

Cancer Vaccine - Regulatory T cells may have a role in poor immune response against tumor antigens

Colon Cancer - Findings support benefits of women having screening colonoscopy at 50

Colon Cancer - USC consortium receives $15 million NCI grant to determine causes

Diagnostics - Antibody test shows 100% sensitivity, specificity in ruling in or out cancer

Drug-induced Toxicity - OGS and FDA to evaluate protein markers predictive of drug toxicity

Financing - Photogen announces revised $9 million financing

Gastric Cancer - First findings presented from phase II pemtumomab trial

Genetic Testing - Nanosphere wins grants for colorectal cancer and hypercoagulation genetic tests

Glioma Therapy - Radiotherapy enhances effect of gene-deleted virus on brain tumors

Head and Neck Cancer - Full enrollment phase II clinical trial announced

Hepatitis C Virus - Virus activates a protein sometimes linked to onset of cancer

Hodgkin Disease - Advanced disease prognostic score useful for predicting stem cell transplant outcome

Immunology - Biotech company says its scientists have created new molecules

Leukemia - Combination clofarabine/cytarabine therapy trial underway

Lung Cancer - Large scale study of tumor marker begins in Germany

Lung Cancer - New class of drugs reduces metastatic tumors by 80% in animal models

Lymphoma - Discovery may lead researchers to genetic mutations causing the cancer

Multiple Myeloma - Alternative to chemotherapy effective for newly diagnosed disease

Oncologic Pain - Radiofrequency ablation technology cleared for relief of bone tumor pain

Ovarian Cancer - Study finds survival prolonged with Taxol + cisplatin

Squamous Cell Carcinoma - Onyx regains all rights to virus platform and initiates repartnering efforts

Stem Cell Transplantation - Low-dose post-transplant interleukin-2 improves myeloid recovery

Tumor Blood Vessels - New vascular targeting agents win patent

Vaccine Development - Collaboration extended on therapeutic vaccines for three oncogenic viruses

Vaccine Development - Prostate cancer vaccine on track for phase III clinical trials

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook